Injection Site Reaction Clinical Trial
Official title:
The Effectiveness of Mechano-Analgesia and Cold Application
Verified date | August 2018 |
Source | Istanbul Saglik Bilimleri University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Fifty-five patients received three subcutaneous heparin injections (165 injections) by the same investigator using additional techniques such as mechano-analgesia and cold application, and without any additional techniques.
Status | Completed |
Enrollment | 165 |
Est. completion date | December 25, 2015 |
Est. primary completion date | March 15, 2015 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 90 Years |
Eligibility |
Inclusion Criteria: - Must be older than 18 years - Open to communication - No complications during the operation - Normal body mass index (BMI; reference range, 18.5-29.9 kg/m2) (d) and - Platelet count (150.000-300.000) - Give consent to participate in the study Exclusion Criteria: - Oral and parenteral anticoagulant treatment for at least 5 days - Infection, scar tissue or incision, and parenteral treatment in their abdominal area - Hematological and allergic disease |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Istanbul Saglik Bilimleri University |
Çelik N, Khorshid L. The Use of ShotBlocker for Reducing the Pain and Anxiety Associated With Intramuscular Injection: A Randomized, Placebo Controlled Study. Holist Nurs Pract. 2015 Sep-Oct;29(5):261-71. doi: 10.1097/HNP.0000000000000105. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Pain Intensity Measure via VAS | The VAS was used to measure pain intensity. The VAS was composed of a 10-cm long line, which had subjective descriptive expressions on both sides (0 cm: no pain and 10 cm: unbearable pain). The individual was asked to make a sign on the line indicating the degree of the pain. The numerical values were recorded by the researcher. | Immediately after injection |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT06093815 -
Prospective Study to Assess Tissue Responses After Injection With Biostimulatory Products
|
N/A | |
Completed |
NCT05007041 -
Simultaneous RZV and aIIV4 Vaccination
|
Phase 4 | |
Completed |
NCT05157230 -
Evaluation of Deltoid Exercises on Injection Site Pain After (BNT162b2) COVID - 19 Vaccination
|
N/A | |
Completed |
NCT05028361 -
Simultaneous mRNA COVID-19 and IIV4 Vaccination Study
|
Phase 4 | |
Completed |
NCT03841396 -
A Study Comparing the Local Tolerability of Two Subcutaneous Heparins in Healthy Volunteers.
|
Phase 4 | |
Recruiting |
NCT04962152 -
Naldebain and Video-assisted Thoracoscopic Surgery
|
Phase 4 | |
Completed |
NCT03183908 -
FLUAD® vs. Fluzone® High-Dose Study
|
Phase 4 | |
Recruiting |
NCT05221333 -
Sorrel 25R Injector - Sorrel Clinical Study Protocol
|
N/A | |
Completed |
NCT05157191 -
Safety of Pediatric COVID-19 Vaccination
|